Voxel Sa operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Voxel Sa with three other
pharmaceutical manufacturers in Europe:
Atrys Health SA
sales of 7.29 million Euro [US$8.08 million]
of which 38%
Medica Group PLC
of the United Kingdom
(£38.97 million [US$50.02 million]
of which 50%
was NightHawk), and
Oncimmune Holdings PLC
based in the United Kingdom
(£240,000.00 [US$308,088.00 ]
of which 100%
was Distribution of testing products).
Voxel Sa reported sales of 170.41 million Polish New Zlotys (US$44.04 million)
December of 2018.
increase of 12.0%
versus 2017, when the company's sales were 152.16 million Polish New Zlotys.
Sales of It Products and Lab Equipment saw an increase
4.3% in 2018, from
52.17 million Polish New Zlotys to 54.42 million Polish New Zlotys.
Not all segments of Voxel Sa experienced an increase in sales in 2018:
sales of Other Segments fell 20.1% to 1.44 million Polish New Zlotys.
(However, this segment's sales were only a very small portion of the company's overall sales).